US Patent

US8021344 — Medicament delivery device configured to produce an audible output

Formulation · Assigned to Intelliject Inc · Expires 2029-11-02 · 3y remaining

Vulnerability score 53/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects a medicament delivery device that produces an audible output, such as an EpiPen.

USPTO Abstract

Medicament delivery devices are described herein. In some embodiments, an apparatus includes a medicament delivery device and an electronic circuit system. The medicament delivery device includes a housing, a medicament container, and a medicament delivery member. The electronic circuit system is coupled to the housing and includes an audible output device and a cover. The housing of the medicament delivery device and the cover of the electronic circuit system collectively define an acoustic enclosure. The audible output device is configured to be disposed within the acoustic enclosure.

Drugs covered by this patent

Patent Metadata

Patent number
US8021344
Jurisdiction
US
Classification
Formulation
Expires
2029-11-02
Drug substance claim
No
Drug product claim
Yes
Assignee
Intelliject Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.